10:00 AM
-
50 minsThe latest HSBC Venture Healthcare report shows increased levels of investment in 2024 with Seed and Series A total investment doubling and investment in preclinical deals already surpassing 2023. The ...
11:00 AM
-
50 minsAdvances in neurodegenerative science have pointed to new paths in the development of medicines that have the potential to dramatically improve patient quality of life. These advances are contributing ...Speakers
1:00 PM
-
50 minsIn a highly competitive landscape, closing your next financing round or inking a partnership with big pharma requires that you effectively capture attention then clearly demonstrate your value proposi ...
2:00 PM
-
90 minsBIO has collaborated with a set of programs focused on entrepreneur development to curate an afternoon of seed-stage company pitches from promising new companies ready to pursue investment or partneri ...Speakers
.jpg)
3:45 PM
-
95 minsBIO has collaborated with a set of programs focused on entrepreneur development to curate an afternoon of seed-stage company pitches from promising new companies ready to pursue investment or partneri ...Speakers
8:45 AM
-
15 minsPlease join to learn the experienced perspective of Sharon Chan, PhD, VP Johnson & Johnson Innovation - JLABS Asia Pacific, for her views on innovation opportunities in the APAC region. As VP JLABS As ...
9:00 AM
-
50 minsAPAC markets are among the largest and fastest growing in the world, with a legacy of successful international collaborations within drug development and direct investment in biotechs. However, post-p ...
10:00 AM
-
50 minsWith oncology continuing to bear ripe opportunities for investors, new modalities such as antibody-drug conjugates (ADCs) and radiopharmaceuticals are garnering significant interest. These approaches ...
11:00 AM
-
60 minsAs the newest iterations of commercial and open-source molecular modeling tools and large-language models lower the barriers for implementing AI applications at biotechs, the challenge for management ...Speakers
.jpeg)
1:00 PM
-
45 minsAsish is the Vice President, Venture Investments at Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and is based at the Johnson & Johnson Innovation Center in San Francisco, California. Asish focuses ...Moderator
2:00 PM
-
50 minsWith the first pricing negotiation results of the Inflation Reduction Act now public, analysts will be diagnosing trends for commercial companies and the implications for their pipelines. Those pipeli ...
.jpg)
3:00 PM
-
50 minsWhile the rate of IPOs this year is slightly increased versus 2023, the market is still much less active since 2021 and hoping the Q3 interest rate cut of 0.5% sparks additional investor support. This ...Speakers
.png)
.jpg)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}